GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager
GeneDx Holdings Corp Logo
GeneDx Holdings Corp
NASDAQ:WGS
Watchlist
Price: 161.95 USD 0.98% Market Closed
Market Cap: 4.7B USD

Wall Street
Price Targets

WGS Price Targets Summary
GeneDx Holdings Corp

Wall Street analysts forecast WGS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WGS is 161.61 USD with a low forecast of 141.4 USD and a high forecast of 178.5 USD.

Lowest
Price Target
141.4 USD
13% Downside
Average
Price Target
161.61 USD
0% Downside
Highest
Price Target
178.5 USD
10% Upside
GeneDx Holdings Corp Competitors:
Price Targets
V3V
Vita 34 AG
42% Upside
OPTIMAX
Optimax Holdings Bhd
45% Upside
FRE
Fresenius SE & Co KGaA
14% Upside
QC7
Q & M Dental Group (Singapore) Ltd
4% Downside
VIJAYA
Vijaya Diagnostic Centre Ltd
16% Upside
OPCH
Option Care Health Inc
19% Upside
AND
Andlauer Healthcare Group Inc
4% Upside
KRSNAA
Krsnaa Diagnostics Ltd
58% Upside

Revenue
Forecast

Revenue Estimate
GeneDx Holdings Corp

For the last 5 years the compound annual growth rate for GeneDx Holdings Corp's revenue is 9%. The projected CAGR for the next 3 years is 27%.

9%
Past Growth
27%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
GeneDx Holdings Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
67%
Average Beat

Net Income
Forecast

Net Income Estimate
GeneDx Holdings Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WGS's stock price target?
Price Target
161.61 USD

According to Wall Street analysts, the average 1-year price target for WGS is 161.61 USD with a low forecast of 141.4 USD and a high forecast of 178.5 USD.

What is GeneDx Holdings Corp's Revenue forecast?
Projected CAGR
27%

For the last 5 years the compound annual growth rate for GeneDx Holdings Corp's revenue is 9%. The projected CAGR for the next 3 years is 27%.

Back to Top